MedTrace Logo

Phase 1 Study of URC102 in Healthy Subjects

NCT01953497 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2017-03-08

No results posted yet for this study

Summary

To assess the safety, tolerability, PK and PD of URC102 in healthy subjects. To evaluate the food effect on PK.

Conditions

  • Healthy

Interventions

DRUG

URC102

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Kyung-Sang Yu, MD, PhD, MBA · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-23
Primary Completion
2013-12-24
Completion
2014-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01953497 on ClinicalTrials.gov